• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA 免疫接种可保护小鼠免受口蹄疫病毒感染。

RNA immunization can protect mice against foot-and-mouth disease virus.

机构信息

Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Cantoblanco, 28049 Madrid, Spain.

出版信息

Antiviral Res. 2010 Mar;85(3):556-8. doi: 10.1016/j.antiviral.2009.12.005. Epub 2009 Dec 18.

DOI:10.1016/j.antiviral.2009.12.005
PMID:20005905
Abstract

In previous work we have reported the immunization of swine using in vitro-transcribed foot-and-mouth disease virus (FMDV) RNA. With the aim of testing whether RNA-induced immunization can mediate protection against viral infection, a group of Swiss adult mice was inoculated with FMDV infectious transcripts. In most inoculated animals viral RNA was detected in serum at 48-72h postinoculation. A group of the RNA-inoculated mice (11 out of 19) developed significant titers of neutralizing antibodies against FMDV. Among those animals that were successfully challenged with infectious virus (15 out of 19), three out of the eight animals immunized upon RNA inoculation were protected, as infectious virus could not be isolated from sera but specific anti-FMDV antibodies could be readily detected. These results suggest the potential of the inoculation of genetically engineered FMDV RNA for virulence and protection assays in the murine model and allow to explore the suitability of RNA-based FMDV vaccination in natural host animals.

摘要

在之前的工作中,我们已经报告了使用体外转录的口蹄疫病毒(FMDV)RNA 对猪进行免疫接种。为了测试 RNA 诱导的免疫接种是否能介导对病毒感染的保护,一组瑞士成年小鼠用 FMDV 传染性转录本进行了接种。在大多数接种动物中,病毒 RNA 在接种后 48-72 小时在血清中被检测到。一组 RNA 接种的小鼠(19 只中的 11 只)产生了针对 FMDV 的中和抗体的显著滴度。在那些用传染性病毒成功挑战的动物中(19 只中的 15 只),在 RNA 接种时免疫的 8 只动物中有 3 只得到了保护,因为无法从血清中分离出传染性病毒,但可以很容易地检测到针对 FMDV 的特异性抗体。这些结果表明,在小鼠模型中接种遗传工程 FMDV RNA 进行毒力和保护试验具有潜力,并允许探索 RNA 为基础的 FMDV 疫苗接种在天然宿主动物中的适用性。

相似文献

1
RNA immunization can protect mice against foot-and-mouth disease virus.RNA 免疫接种可保护小鼠免受口蹄疫病毒感染。
Antiviral Res. 2010 Mar;85(3):556-8. doi: 10.1016/j.antiviral.2009.12.005. Epub 2009 Dec 18.
2
DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.表达B细胞和T细胞表位的DNA疫苗能够在缺乏特异性体液免疫反应的情况下保护小鼠免受口蹄疫病毒感染。
Vaccine. 2006 May 1;24(18):3889-99. doi: 10.1016/j.vaccine.2006.02.028. Epub 2006 Mar 3.
3
Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.合成 RNA 的递呈可以增强针对口蹄疫病毒(FMDV)疫苗在小鼠中的免疫原性。
Vaccine. 2013 Sep 13;31(40):4375-81. doi: 10.1016/j.vaccine.2013.07.008. Epub 2013 Jul 13.
4
Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection.给新生小鼠接种口蹄疫病毒 RNA 的非编码区可快速诱导对病毒感染的坚固且广泛的保护。
Antiviral Res. 2011 Dec;92(3):500-4. doi: 10.1016/j.antiviral.2011.10.005. Epub 2011 Oct 13.
5
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.控制口蹄疫新策略的研发:标记疫苗和抗病毒药物。
Biologicals. 2005 Dec;33(4):227-34. doi: 10.1016/j.biologicals.2005.08.009. Epub 2005 Nov 14.
6
Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.口蹄疫病毒聚合酶3D在猪体内的免疫原性和T细胞识别
Virology. 2004 May 1;322(2):264-75. doi: 10.1016/j.virol.2004.01.027.
7
An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.一种基于基因工程减毒伪狂犬病病毒的口蹄疫疫苗研发方法:仅使用VP1基因进行的一项实验可在猪体内引发针对口蹄疫和伪狂犬病的抗体反应。
Vaccine. 2004 Jun 2;22(17-18):2129-36. doi: 10.1016/j.vaccine.2003.12.005.
8
Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.以猪IgG重链恒定区或β-半乳糖苷酶作为免疫原性表位载体的融合蛋白诱导的抗口蹄疫病毒免疫反应的比较。
Virology. 2004 Oct 25;328(2):274-81. doi: 10.1016/j.virol.2004.07.025.
9
Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.编码口蹄疫病毒P12A和3C以及猪白细胞介素-18的质粒的免疫原性。
Antiviral Res. 2007 Oct;76(1):59-67. doi: 10.1016/j.antiviral.2007.05.003. Epub 2007 Jun 4.
10
Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.用表达口蹄疫病毒衣壳前体编码区的减毒重组伪狂犬病病毒免疫猪诱导保护性免疫。
Vaccine. 2008 May 23;26(22):2714-22. doi: 10.1016/j.vaccine.2008.03.020. Epub 2008 Apr 1.

引用本文的文献

1
A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants.一种表达伪狂犬病病毒gD的自我扩增mRNA疫苗可诱导针对强毒株突变体的强大免疫力。
NPJ Vaccines. 2025 Aug 14;10(1):193. doi: 10.1038/s41541-025-01251-5.
2
Development of an mRNA vaccine encoding IHNV glycoprotein protects rainbow trout (Oncorhynchus mykiss) from infection.编码传染性造血器官坏死病毒糖蛋白的mRNA疫苗的研发可保护虹鳟(Oncorhynchus mykiss)免受感染。
NPJ Vaccines. 2025 Jul 22;10(1):162. doi: 10.1038/s41541-025-01222-w.
3
Porcine Reproductive and Respiratory Syndrome Virus: Challenges and Advances in Vaccine Development.
猪繁殖与呼吸综合征病毒:疫苗研发的挑战与进展
Vaccines (Basel). 2025 Feb 28;13(3):260. doi: 10.3390/vaccines13030260.
4
Role of T Follicular Helper Cells in Viral Infections and Vaccine Design.滤泡辅助性T细胞在病毒感染和疫苗设计中的作用。
Cells. 2025 Mar 29;14(7):508. doi: 10.3390/cells14070508.
5
The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine.疫苗与佐剂联合使用以预防牛群中高发性传染病的发生。
Front Vet Sci. 2023 Oct 11;10:1243835. doi: 10.3389/fvets.2023.1243835. eCollection 2023.
6
B and T Cell Epitopes of the Incursionary Foot-and-Mouth Disease Virus Serotype SAT2 for Vaccine Development.入侵性口蹄疫病毒血清型 SAT2 的 B 和 T 细胞表位,用于疫苗开发。
Viruses. 2023 Mar 21;15(3):797. doi: 10.3390/v15030797.
7
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases.mRNA 疫苗在新发动物源性和人畜共患病中的开发。
Viruses. 2022 Feb 15;14(2):401. doi: 10.3390/v14020401.
8
Vaccines for COVID-19: The current state of play.COVID-19 疫苗:当前进展状况。
Paediatr Respir Rev. 2020 Sep;35:43-49. doi: 10.1016/j.prrv.2020.06.010. Epub 2020 Jun 18.
9
Advances in mRNA Vaccines for Infectious Diseases.mRNA 疫苗在传染病防治中的进展
Front Immunol. 2019 Mar 27;10:594. doi: 10.3389/fimmu.2019.00594. eCollection 2019.
10
Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.I 型干扰素通过脂质体递送 mRNA 疫苗来抑制抗原特异性免疫应答的诱导。
Mol Ther. 2013 Jan;21(1):251-9. doi: 10.1038/mt.2012.202. Epub 2012 Sep 25.